1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Blood Plasma Derivatives Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Blood Plasma Derivatives Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Blood Plasma Derivatives Market Regional Analysis
6.2 North America Blood Plasma Derivatives Market Revenue 2020-2028 (US$ Million)
6.3 North America Blood Plasma Derivatives Market Forecast Analysis
7. North America Blood Plasma Derivatives Market Analysis – by Type
7.1 Albumin
- 7.1.1 Overview
- 7.1.2 Albumin: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Factor VIII
- 7.2.1 Overview
- 7.2.2 Factor VIII: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Factor IX
- 7.3.1 Overview
- 7.3.2 Factor IX: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Immunoglobulin
- 7.4.1 Overview
- 7.4.2 Immunoglobulin: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.5 Hyperimmune Globulin
- 7.5.1 Overview
- 7.5.2 Hyperimmune Globulin: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Blood Plasma Derivatives Market Analysis – by Application
8.1 Hemophilia
- 8.1.1 Overview
- 8.1.2 Hemophilia: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Hypogammaglobulinemia
- 8.2.1 Overview
- 8.2.2 Hypogammaglobulinemia: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Immunodeficiency Diseases
- 8.3.1 Overview
- 8.3.2 Immunodeficiency Diseases: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 von Willebrand's Diseases
- 8.4.1 Overview
- 8.4.2 von Willebrand's Diseases: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Blood Plasma Derivatives Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: North America Blood Plasma Derivatives Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. North America Blood Plasma Derivatives Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Blood Plasma Derivatives Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 North America Blood Plasma Derivatives Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Blood Plasma Derivatives Market Breakdown, by Type
- 10.2.1.1.2 US: North America Blood Plasma Derivatives Market Breakdown, by Application
- 10.2.1.1.3 US: North America Blood Plasma Derivatives Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Blood Plasma Derivatives Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Blood Plasma Derivatives Market Breakdown, by Application
- 10.2.1.2.3 Canada: North America Blood Plasma Derivatives Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Blood Plasma Derivatives Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Blood Plasma Derivatives Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Blood Plasma Derivatives Market Breakdown, by Application
- 10.2.1.3.3 Mexico : North America Blood Plasma Derivatives Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Grifols SA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 SK Plasma Co Ltd
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Octapharma AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Monobind Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Intas Pharmaceuticals Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Takeda Pharmaceutical Co Ltd
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 CSL Behring LLC
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 LFB SA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Kedrion SpA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Blood Plasma Derivatives Market
